Tag: psychiatric drugs
Xanax Nation
In this blog post, Andy White highlights the role Xanax plays in silencing political dissent and keeping the public complacent. Instead of expressing anger...
Medicine Can Soothe a Troubled Mind, but Not Without Costs
From The New York Times: In a new book, Blue Dreams, psychologist and patient Lauren Slater critiques the drug-based model of psychiatric care, debunking the chemical...
Two Who Died in Psychiatric Hospitals Were Improperly Medicated
From The Boston Globe: According to a new report from the Disability Law Center in Boston, two patients who died at Arbour Health System psychiatric...
Media Ignoring Crucial Factor in Florida School Shooting
From WND: Although a disturbing number of perpetrators of recent mass shootings and murders have been on psychiatric medication prior to committing their crimes, the media has...
Anger – What Is It REALLY a Symptom Of?
I want to learn how to control my anger. But to get rid of it would be to get rid of a part of myself. It would also feel like swallowing down injustice. Such a drug probably doesn't exist, but what if there were an antidepressant that could make me stop disliking mental health professionals? The idea feels scary to me, like some kind of mind control pill.
Life Sentence: Life Behind the Bars of the Mental Health System
The minute you sit down in the chair in a mental health professional's office, you’re no longer seen as a person. The mental health system is incapable of seeing past the solid wall of your current label. Their only cure is drugs. "First Do No Harm" are powerful words. It’s unfortunate they don’t apply to psychiatry.
Mental Health Inc: A New Book by Art Levine
From AlterNet: A new book my Art Levine, Mental Health Inc: How Corruption, Lax Oversight and Failed Reforms Endanger Our Most Vulnerable Citizens, exposes the greed...
Therapeutic Alliance: Implications for Practice and Policy
In this piece for Psychiatric Services, Dr. Sandra Steingard comments on the implications of a recent meta-analysis demonstrating the positive effects of the therapeutic alliance on pharmacologic...
Reexamining Schizophrenia as a Brain Disease
Schizophrenia has occupied, and continues to occupy, a position of great import in psychiatry, and it is frequently used to assert the supposed biological nature of the field. What evidence is there to suggest that what we call schizophrenia is a disease of the brain? Surprisingly, very little.
Real People, Real Side Effects: Stories of Sexual Dysfunction
Research shows that psychiatric drugs seem to have an impact on libido, so I decided to collect personal stories to complement the evidence of side effects from psychotropic medication already available. Libido can be directly linked with wellness, and patients need more information to make the choice right for them.
The Issue of Over-Diagnosing in Psychiatry
From The Concordian: On October 30th, Dr. Joel Paris, a professor of psychiatry at McGill University, gave a lecture about the dangers and consequences of...
Learning About Psychiatric Drug Withdrawal
We held the first course ever on psychiatric drug withdrawal on 12 June 2017 in Copenhagen. The course was open to patients, relatives, psychologists, doctors and other social and healthcare workers, and 77 people participated.
Antidepressant to Blame for Frank Sinatra’s Failing Health
From Fox News: According to Frank Sinatra's manager Eliot Weisman, Sinatra suffered from several adverse effects of the antidepressant Elavil during his final years.
"...there was...
Health Care? More Like Health Scare!
From the Lown Institute: For pharmaceutical companies who use scare tactics to sell drugs, every day is like Halloween. This list of egregious advertisements shows...
Tranquilizing Humanity into Oblivion: A Warning from Nathan S. Kline
Widely heralded as the father of American psychopharmacology, Kline insisted that his discoveries were adjunctive to psychotherapy, not replacements. The psychopharmacology of Kline's era recognized that medications are a blunt instrument.
Mortality of People Using Mental Health Services and Medications
153,451 deaths were registered in Australia in the period 10 August 2011 to 27 September 2012. 75,858 of these deaths were registered for persons who had accessed mental health-related treatments. These deaths accounted for 49.4% of all deaths in this period.
Dr. Gordon Warme: The Relationship Between Culture and Psychiatric ‘Disorders’
This week we interview Dr Gordon Warme on the dominance of biological psychiatry and the relationship between culture and psychiatric ‘disorders’.
David Mielke: Educating in the Era of Psychiatric Diagnosis
This week we interview psychology graduate and teacher David Mielke who has become increasingly concerned about the number of children in the education system that have a psychiatric diagnosis and are on psychiatric drugs.
Irving Kirsch: The Placebo Effect and What It Tells Us About...
Dr Irving Kirsch is Associate Director of the Program in Placebo Studies and lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center. He joins us this week to discuss his research into the placebo effect and what it tells us about the efficacy of antidepressant drugs.
FDA Approves Drug for the Annoyingly Cheerful (The Onion)
From The Onion: "Made by Pfizer, Despondex is the first drug designed to treat the symptoms of excessive perkiness."
Video →
Peter Breggin, MD: The Conscience of Psychiatry (part 2)
Dr Beggin tells us about recent developments with the Michelle Carter trial, and we discuss alternatives to psychiatric drugs and the value of the therapeutic relationship.
Bob Fiddaman: Taking on the Pharmaceutical Regulators and the Seroxat Scandal
Today on the MIA podcast we talk to Bobby Fiddaman about his experiences of the mental health system, his research and campaigning over the years and his relationships with the UK and US pharmaceutical regulatory bodies.
Vanda Puts Antipsychotic Side Effect Front and Center in TV Ads
From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...
Peter Breggin, MD: The Conscience of Psychiatry
On this episode of the MIA Radio podcast, we present part one of an interview with Dr. Peter Breggin about his career, his views on psychiatry and recent developments with the Michelle Carter trial in which he testified as an expert medical witness.
Jim van Os: Rethinking Biological Psychiatry
Psychiatrist Jim van Os is Chairman of the Department of Psychiatry and Psychology at Maastricht University Medical Centre, Maastricht, The Netherlands. He challenges current diagnostic conceptions of schizophrenia and other mental disorders, and offers a vision for creating a new paradigm of mental health care.































